OHSU Knight Cancer Institute Hematology Oncology — Portland, Oregon

OHSU Knight Cancer Institute Hematology Oncology is a clinical research site located in Portland, Oregon, United States 97239.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

OHSU Knight Cancer Institute Hematology Oncology has participated in 4 clinical trials with 3 currently active.

Therapeutic areas: Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia.

Sponsors: Beam Therapeutics Inc., Genentech, Inc., Spexis AG.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for OHSU Knight Cancer Institute Hematology Oncology?

OHSU Knight Cancer Institute Hematology Oncology has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has OHSU Knight Cancer Institute Hematology Oncology conducted?

OHSU Knight Cancer Institute Hematology Oncology has 4 clinical trials on record, with 3 currently active. Their work covers Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia.

Is OHSU Knight Cancer Institute Hematology Oncology accredited by Crixeo Health?

OHSU Knight Cancer Institute Hematology Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about OHSU Knight Cancer Institute Hematology Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.